J 2014

Cancer incidence and mortality in the Czech Republic

DUŠEK, Ladislav, Jan MUŽÍK, Denisa MALÚŠKOVÁ, Ondřej MÁJEK, Tomáš PAVLÍK et. al.

Basic information

Original name

Cancer incidence and mortality in the Czech Republic

Authors

DUŠEK, Ladislav (203 Czech Republic, guarantor, belonging to the institution), Jan MUŽÍK (203 Czech Republic, belonging to the institution), Denisa MALÚŠKOVÁ (203 Czech Republic, belonging to the institution), Ondřej MÁJEK (203 Czech Republic, belonging to the institution), Tomáš PAVLÍK (203 Czech Republic, belonging to the institution), Jana KOPTÍKOVÁ (203 Czech Republic, belonging to the institution), B. MELICHAR (203 Czech Republic), T. BUCHLER (203 Czech Republic), J. FINEK (203 Czech Republic), D. CIBULA (203 Czech Republic), M. BABJUK (203 Czech Republic), M. SVOBODA (203 Czech Republic), Rostislav VYZULA (203 Czech Republic), A. RYSKA (203 Czech Republic), M. RYSKA (203 Czech Republic), J. PETERA (203 Czech Republic) and J. ABRAHAMOVÁ (203 Czech Republic)

Edition

Klinická onkologie, Praha, Česká lékařská společnost J. E. Purkyně, 2014, 0862-495X

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30200 3.2 Clinical medicine

Country of publisher

Czech Republic

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

RIV identification code

RIV/00216224:14110/14:00080160

Organization unit

Faculty of Medicine

Keywords in English

epidemiology; incidence; mortality; Czech Republic; neoplasms multiple primary; staging; Czech National Cancer Registry

Tags

Tags

Reviewed
Změněno: 4/2/2015 17:30, Soňa Böhmová

Abstract

V originále

The purpose of this study is to summarize long-term trends in the cancer burden and to provide up-to-date estimates of incidence and mortality rates after 2011.

Links

NT13660, research and development project
Name: Hodnocení kvality multimodální péče u nemocných s jaterními metastázami kolorektálního karcinomu v rámci komplexních onkologických center ČR Multicentrická studie
Investor: Ministry of Health of the CR